abrdn Healthcare Investors Valuation Multiples

abrdn Healthcare Investors is valued at $1.2B as of November 2026, a 11.3x revenue multiple. In the last fiscal year, abrdn Healthcare Investors revenue was $109M.

abrdn Healthcare Investors Overview

About abrdn Healthcare Investors

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.


Founded

1986

HQ

United States

Employees

N/A

Website

N/A

Financials (Last FY)

Revenue: $109M
Net Income: $99M

EV

$1.2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

abrdn Healthcare Investors Financials

abrdn Healthcare Investors reported last fiscal year revenue of $109M.

In the same fiscal year, abrdn Healthcare Investors generated $99M in net income.


abrdn Healthcare Investors P&L

In the most recent fiscal year, abrdn Healthcare Investors reported revenue of $109M and net income of $99M.

abrdn Healthcare Investors is profitable as of last fiscal year, with net margin of 90%.

See analyst estimates for abrdn Healthcare Investors
Last FY202320242025202620272028
Revenue$109M$90M$165M$100M
Net Profit$99M$88M$163M$99M
Net Margin90%98%99%99%

Financial data powered by Morningstar, Inc.

abrdn Healthcare Investors Stock Performance

abrdn Healthcare Investors has current market cap of $1.2B, and enterprise value of $1.2B.

Market Cap Evolution


abrdn Healthcare Investors' stock price is $21.56.

abrdn Healthcare Investors share price increased by 0.8% in the last 30 days, and by 13.8% in the last year.

abrdn Healthcare Investors has an EPS (earnings per share) of $1.72.

See more trading valuation data for abrdn Healthcare Investors
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.2B$1.2B1.5%0.8%-13.8%$1.72

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

abrdn Healthcare Investors Valuation Multiples

abrdn Healthcare Investors trades at 11.3x EV/Revenue multiple.

See NTM and 2027E valuation multiples for abrdn Healthcare Investors

abrdn Healthcare Investors Financial Valuation Multiples

As of November 5, 2026, abrdn Healthcare Investors has market cap of $1.2B and EV of $1.2B.

abrdn Healthcare Investors has a P/E ratio of 12.5x.

Last FY202320242025202620272028
EV/Revenue11.3x13.7x7.5x12.4x
P/E12.5x13.9x7.5x12.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified abrdn Healthcare Investors Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

abrdn Healthcare Investors Margins & Growth Rates

In the most recent fiscal year, abrdn Healthcare Investors reported net margin of 90%.

See estimated margins and future growth rates for abrdn Healthcare Investors

abrdn Healthcare Investors Margins

Last FY20242025202720282029
Net Margin90%99%99%

abrdn Healthcare Investors Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth83%(39%)
Net Profit Growth85%(40%)

Data powered by FactSet, Inc. and Morningstar, Inc.

abrdn Healthcare Investors Operational KPIs

Access forward-looking KPIs for abrdn Healthcare Investors
Last FY202320242025202620272028
G&A Expenses to Revenue1%1%1%1%
Opex to Revenue10%2%1%1%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

abrdn Healthcare Investors Competitors

abrdn Healthcare Investors competitors include lnterise Trust, AFP Cuprum, Kinea Indices Precos, Frey, Okasan Securities, Icade, Tetragon Financial Group, Viel & Cie, FII Ancar IC and Oakley Capital.

Most abrdn Healthcare Investors public comparables operate across Asset Management.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
lnterise Trust$373M$266M5.3x-7.4x-
AFP Cuprum$232M$163M4.5x-6.4x-
Kinea Indices Precos$181M-6.9x---
Frey$260M$170M10.4x10.1x15.9x18.6x
Okasan Securities$634M-2.0x2.1x--
Icade$1.5B($55M)3.3x13.9x(89.8x)15.1x
Tetragon Financial Group------
Viel & Cie$1.4B$307M0.9x-4.1x-

This data is available for Pro users. Sign up to see all abrdn Healthcare Investors competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About abrdn Healthcare Investors

When was abrdn Healthcare Investors founded?abrdn Healthcare Investors was founded in 1986.
Where is abrdn Healthcare Investors headquartered?abrdn Healthcare Investors is headquartered in United States.
Is abrdn Healthcare Investors publicly listed?Yes, abrdn Healthcare Investors is a public company listed on NYSE.
What is the stock symbol of abrdn Healthcare Investors?abrdn Healthcare Investors trades under HQH ticker.
When did abrdn Healthcare Investors go public?abrdn Healthcare Investors went public in 1987.
Who are competitors of abrdn Healthcare Investors?abrdn Healthcare Investors main competitors include lnterise Trust, AFP Cuprum, Kinea Indices Precos, Frey, Okasan Securities, Icade, Tetragon Financial Group, Viel & Cie, FII Ancar IC, Oakley Capital.
What is the current market cap of abrdn Healthcare Investors?abrdn Healthcare Investors' current market cap is $1.2B.
What is the current revenue of abrdn Healthcare Investors?abrdn Healthcare Investors' last fiscal year revenue is $109M.
What is the current EV/Revenue multiple of abrdn Healthcare Investors?Current revenue multiple of abrdn Healthcare Investors is 11.3x.
Is abrdn Healthcare Investors profitable?No, abrdn Healthcare Investors is not profitable.
How many companies abrdn Healthcare Investors has acquired to date?abrdn Healthcare Investors hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies abrdn Healthcare Investors has invested to date?abrdn Healthcare Investors hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to abrdn Healthcare Investors

Lists including abrdn Healthcare Investors

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial